| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―07 |
SARS-CoV-2 NSP16 promotes IL-6 production by regulating the stabilization of HIF-1α |
Xiaoli Mou, Fan Luo, Weihao Zhang, Qi Cheng, Jussi Hepojoki, Shaowei Zhu, et al. (+8) Yuanyuan Liu, Hairong Xiong, Deyin Guo, Jingyou Yu, Liangjun Chen, Yirong Li, Wei Hou, Shuliang Chen |
| 2 |
[GO] |
2023―Sep―28 |
Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches |
Gujie Wu, Jiabin Zhou, Hefei Ren, Yiran Qin, Diandian Qian, Qin Hu, et al. (+6) Peng Xu, Tao Yu, Huiyun Ma, Hongyu Chen, Min He, Jiayu Shi |
| 3 |
[GO] |
2023―Jul―07 |
SARS-CoV-2 vaccine breakthrough infections (VBI) by Omicron variant (B.1.1.529) and consequences in structural and functional impact |
Zainularifeen Abduljaleel, Sami Melebari, Mohammed Athar, Saied Dehlawi, S. Udhaya Kumar, Syed A. Aziz, et al. (+4) Anas Ibrahim Dannoun, Shaheer M. Malik, Jasheela Thasleem, C. George Priya Doss |
| 4 |
[GO] |
2022―Dec―13 |
COVID-19 signalome: Potential therapeutic interventions |
Kenneth Lundstrom, Altijana Hromić-Jahjefendić, Esma Bilajac, Alaa A.A. Aljabali, Katarina Baralić, Nagwa A. Sabri, et al. (+16) Eslam M. Shehata, Mohamed Raslan, Sara A. Raslan, Ana Cláudia B.H. Ferreira, Lidiane Orlandi, Ángel Serrano-Aroca, Vladimir N. Uversky, Sk. Sarif Hassan, Elrashdy M. Redwan, Vasco Azevedo, Khalid J. Alzahrani, Khalaf F. Alsharif, Ibrahim F. Halawani, Fuad M. Alzahrani, Murtaza M. Tambuwala, Debmalya Barh |
| 5 |
[GO] |
2022―Oct―15 |
COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity |
Kenneth Lundstrom, Altijana Hromić-Jahjefendić, Esma Bilajac, Alaa A.A. Aljabali, Katarina Baralić, Nagwa A. Sabri, et al. (+12) Eslam M. Shehata, Mohamed Raslan, Ana Cláudia B.H. Ferreira, Ángel Serrano-Aroca, Murtaza M. Tambuwala, Vladimir N. Uversky, Vasco Azevedo, Khalid J. Alzahrani, Khalaf F. Alsharif, Ibrahim F. Halawani, Fuad M. Alzahrani, Debmalya Barh |
| 6 |
[GO] |
2022―Apr―21 |
Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2 |
Chithravel Vadivalagan, Anushka Shitu, Siva Kamalakannan, Ruei-Ming Chen, Ángel Serrano-Aroca, Vijay Mishra, et al. (+8) Alaa A.A. Aljabali, Sachin Kumar Singh, Dinesh Kumar Chellappan, Gaurav Gupta, Kamal Dua, Mohamed El-Tanani, Murtaza M. Tambuwala, Anand Krishnan |
| 7 |
[GO] |
2021―Aug―23 |
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder |
Aziz Rodan Sarohan, Murat Kızıl, Ahmet Çağkan İnkaya, Shokhan Mahmud, Muhammad Akram, Osman Cen |
| 8 |
[GO] |
2021―Jun―17 |
TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2 |
Yinfang Wang, Yingzhe Fan, Yitong Huang, Tao Du, Zongjun Liu, Dekui Huang, et al. (+3) Ying Wang, Nanping Wang, Peng Zhang |
| 9 |
[GO] |
2020―Jul―22 |
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19 |
Ramarao Poduri, Gaurav Joshi, Gowraganahalli Jagadeesh |
| 10 |
[GO] |
2020―Jul―03 |
Janus sword actions of chloroquine and hydroxychloroquine against COVID-19 |
Xuesong Chen, Jonathan D. Geiger |
|
